BackRegencell Bioscience Holdings Overview

Regencell Bioscience Holdings Current Assets

Latest current assets for RGC: $2.4M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.36M
↓ 64.21% YoYΔ $-4.23M vs prior year quarter

Peer average

Loading

Regencell Bioscience Holdings Current Assets History

Loading

Regencell Bioscience Holdings vs. peers: Current Assets Comparison

Loading

Regencell Bioscience Holdings Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Regencell Bioscience Holdings (RGC) FAQ

As of the most recent data (December 2025), RGC shows a current assets of $2.4M. That compares with $6.6M in the prior-year period — down 64.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RGC's current assets is now $2.4M (was $6.6M) — a 64.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Regencell Bioscience Holdings is outperforming or lagging.

Tracking RGC's current assets over time shows whether Regencell Bioscience Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $6.6M in the prior-year period — down 64.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Regencell Bioscience Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.4M) with ownership activity and broader fundamentals.

Regencell Bioscience Holdings's current assets is $2.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.